CHITOSAN-ALGINATE HYDROGEL BEADS AS CARRIER TO ALBUMIN EVALUATED IN VITRO FOR ORAL PROTEINS ADMINISTRATION
Journal Title: WORLD JOURNAL PHARMACY AND PHARMACEUTICAL SCIENCE - Year 2019, Vol 8, Issue 8
Abstract
The oral-colon specific drug delivery is one of the most promising ways to increase the bioavailability of many bioactive compounds and nowadays chitosan (CS) and alginate (AL) plays a very important role in the pharmaceutical industry. In this study we comparatively investigate the in vitro release of bovine serum albumin (BSA), through CS and CS-AL hydrogel beads, and the effect of pH related swelling on the release of the protein for potential applications in oral protein delivery. The pH-sensitive hydrogel beads composed of chitosan (CS) and alginate (AL) were developed by coacervation and were characterized by morphology, swelling ratio and FT-IR spectrum analyses. The releases profile assays were analyzed in vitro in simulated gastric fluid (SGF) and simulated colonic fluid (SCF), using an orbital shaker at 100 rpm and 37°C and studies of swelling properties of beads were also investigate in same condictions. The morphological characterization shown CS-AL hydrogel beads, display a smoother surface, when compared with CS beads and regarding internal stucture, CS beads seems sponge-like in comparison with CS-AL hydrogel beads, which have an uniform matrix and a lower porosity. The profile of the absorption spectrum of hydrogels shows changes in the modes of peak vibrations when compared to isolated polymer spectrums suggests the formation of the polyelectrolyte complex between CS and AL. The hydrogel beads remained stable in an acid medium with an average size of approximately 1000 μm. BSA delivery in hydrogel beads using 10 mg/mL of protein was sustained for SCF, but delayed for SGF, remaining stable in this medium. According the results, CS-AL hydrogel beads were pH-sensitive and could be employable in oral delivery systems for therapeutic proteins.
Authors and Affiliations
Dr. Rosa Valéria Amorim
Keywords
Related Articles
- EP ID EP668349
- DOI -
- Views 123
- Downloads 0
GENETIC VARIATION AND POLYMORPHISM IDENTIFICATION IN MICE TREATED WITH TRAMADOL AND TRAMACET USING AFLP FINGERPRINTING "COMPARATIVE STUDY"
Tramadol and tramadol/ acetaminophen (tramacet) as a centrally acting analgesic are commonly prescribed as effective in treatment of acute and chronic moderate to severe pain. The present study was established to investi...
ANTIBIOTIC QUALITY MONITORING: DETERMINATION OF COTRIMOXAZOLE USED IN TREATMENT IN ANTIBIOTIC RESISTANCE CASES AT TASIKMALAYA CITY HEALTH CENTER, INDONESIA
Objective: Cotrimoxazole is a broad spectrum anti-microbial used in the management of Acute Respiratory Infection (ARIs) disease. The good quality of antibiotics greatly determines the effectiveness and success in therap...
KNOWLEDGE, PERCEPTIONS AND PRACTICES OF COMMUNITY PHARMACISTS ON THE USE OF PHYTOPHARMACEUTICALS IN JOS, NIGERIA
The global increase in the use of phytopharmaceutical products (herbal medicinal formulations) partly arises from the misconception that „natural‟ means “safe or risk-free”. To provide optimal pharmaceutical care, pharma...
TREATMENT OF TEMPOROMANDIBULAR JOINT DYSFUNCTION CASES AT TEACHING HOSPITAL, AL-KHOMS, LIBYA
The Temporomandibular joint is the joint that connects your jaw to your skull. When this joint is injured or damaged, it can lead to a localized pain disorder called Temporomandibular joint dysfunction (TMJD). It is char...
COMPARATIVE BIOEQUIVALENCE STUDY OF DIFFERENT BRANDS OF VALSARTAN TABLETS MARKETED IN BANGLADESH BY DISSOLUTION MODELING AND QUALITY CONTROL TESTS
Valsartan is an angiotensin II receptor antagonist (commonly called an ARB, or angiotensin receptor blocker), that is selective for the type I (AT1) angiotensin receptor. Valsartan is mainly used for treatment of high bl...